KRYS Operating Cash Flow (Statement)

Krystal Biotech Inc · Operating Cash Flow (Statement)

KRYS logo

KRYS Operating Cash Flow (Statement)

Latest reported$272.34M
KRYS TTM Cash from Operations (-$3.89M → $272.34M)
High-resolution chart · PNG

KRYS operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Krystal Biotech Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
272,338,000
250,278,000
200,865,000
176,200,000
195,398,000
138,501,000
123,420,000
63,345,000
-16,738,000
-46,760,000
-88,804,000
-103,901,000
-102,363,000
-111,232,000
-100,569,000
-99,140,000
-86,707,000
-53,777,000
-47,938,000
-35,062,000
-34,573,000
-29,510,000
-26,083,000
-25,105,000
-22,582,000
-21,725,000
-18,713,000
-15,185,000
-12,882,000
-10,291,000
-9,445,000
-8,054,000
-7,212,000
-6,002,000
-3,890,000
-2,624,000
-1,837,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.